Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Abu-Abid

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The European Journal of Surgery = Acta Chirurgica|January 5, 2002
Effect of methylene blue on resuscitation after haemorrhagic shockI Jeroukhimov, A Weinbroum, R Ben-Avraham, et al.
Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.
Harefuah|July 27, 2000
[The diagnosis and treatment of Fournier's gangrene]M Cohen, E Tamir, S Abu-Abid, et al.
The Journal of Clinical Investigation|March 21, 1998
Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shockD Aderka, P Sorkine, S Abu-Abid, et al.
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
Harefuah|October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]S Abu-Abid, M Gutman, D Lev, et al.
Cancer|September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancerM Gutman, S Abu-Abid, P Sorkine, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1995
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustmentP Sorkin, S Abu-Abid, D Lev, et al.
Annals of Surgical Oncology|April 13, 2000
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerationsJ Issakov, O Merimsky, M Gutman, et al.
Mediators of Inflammation|January 1, 1994
Thromboxane modulates endothelial permeabilityJ M Klausner, S Abu-Abid, J S Alexander, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The European Journal of Surgery = Acta Chirurgica|January 5, 2002
Effect of methylene blue on resuscitation after haemorrhagic shockI Jeroukhimov, A Weinbroum, R Ben-Avraham, et al.
Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.
Harefuah|July 27, 2000
[The diagnosis and treatment of Fournier's gangrene]M Cohen, E Tamir, S Abu-Abid, et al.
The Journal of Clinical Investigation|March 21, 1998
Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shockD Aderka, P Sorkine, S Abu-Abid, et al.
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
Harefuah|October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]S Abu-Abid, M Gutman, D Lev, et al.
Cancer|September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancerM Gutman, S Abu-Abid, P Sorkine, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1995
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustmentP Sorkin, S Abu-Abid, D Lev, et al.
Annals of Surgical Oncology|April 13, 2000
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerationsJ Issakov, O Merimsky, M Gutman, et al.
Mediators of Inflammation|January 1, 1994
Thromboxane modulates endothelial permeabilityJ M Klausner, S Abu-Abid, J S Alexander, et al.
Pageof 2